JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, L.
Right arrow Articles by Burcher, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, L.
Right arrow Articles by Burcher, E.

Vol. 302, Issue 2, 627-635, August 2002

Roles of Substance P Receptors in Human Colon Circular Muscle: Alterations in Diverticular Disease

Lu Liu, Fei Shang, Irit Markus and Elizabeth Burcher

Department of Physiology and Pharmacology, University of New South Wales, Sydney, New South Wales, Australia

The characteristics of [125I]Bolton-Hunter[Sar9,Met(O2)11]substance P ([125I]BH-SarSP) binding were investigated in membranes of human ascending, transverse, distal, and sigmoid colon circular muscle. Binding of [125I]BH-SarSP was of high affinity (KD = 68 nM) and low capacity (Bmax = 0.31 fmol/mg of wet weight tissue), and showed no regional differences. [125I]BH-SarSP binding was inhibited by SP approx  [Pro9]SP >=  (2S,3S)-3-(2-methoxybenzylamino)-2-phenylpiperidine (CP99994) neurokinin (NK) A >=  neuropeptide gamma  > [Lys5,MeLeu9,Nle10]-NKA(4-10) approx  (S)-N-methyl-N[4-acetylamino-4-phenylpiperidino)-2-(3,4-dichlorophenyl) butyl]benzamide (SR48968) senktide, suggesting binding to NK-1 sites. Most agonists seemed to bind to two sites. In autoradiographic studies, dense binding for [125I]BH-SarSP was associated with submucosal and longitudinal muscle blood vessels, and the submucosal margin of circular muscle (corresponding to interstitial cells of Cajal), with moderate binding over most of the circular muscle. In normal colon circular muscle strips, [Pro9]SP was almost ineffective, and SP caused contractions with pD2 values of 5.3 to 5.7. No regional differences were observed in potency or efficacy. Responses to SP were inhibited by the NK-2 receptor antagonist SR48968, but not by NK-1 antagonist CP99994, indicating the involvement of NK-2 rather than NK-1 receptors. Atropine significantly inhibited contractions induced by SP, indicating a minor cholinergic component. Contractile responses to SP were considerably reduced in preparations from patients with diverticular disease, and marginally reduced in ulcerative colitis compared with control. This study clearly demonstrates an NK-1 binding site on human colon circular muscle, but its role in this tissue remains unclear and may not involve contractile mechanisms. The attenuated contractility in specimens with diverticular disease may reflect disease-related alterations of the tachykinin receptor system.


0022-3565/02/3022-0627$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
L. Liu, F. Shang, M. J. Morgan, D. W. King, D. Z. Lubowski, and E. Burcher
Cyclooxygenase-Dependent Alterations in Substance P-Mediated Contractility and Tachykinin NK1 Receptor Expression in the Colonic Circular Muscle of Patients with Slow Transit Constipation
J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 282 - 289.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. Burcher, F. Shang, F. J. Warner, Q. Du, D. Z. Lubowski, D. W. King, and L. Liu
Tachykinin NK2 Receptor and Functional Mechanisms in Human Colon: Changes with Indomethacin and in Diverticular Disease and Ulcerative Colitis
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 170 - 178.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Chen, D. Redelman, S. Ro, S. M. Ward, T. Ordog, and K. M. Sanders
Selective labeling and isolation of functional classes of interstitial cells of Cajal of human and murine small intestine
Am J Physiol Cell Physiol, January 1, 2007; 292(1): C497 - C507.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. R. Kovac, T. Chrones, H. G. Preiksaitis, and S. M. Sims
Tachykinin Receptor Expression and Function in Human Esophageal Smooth Muscle
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 513 - 520.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
F Guagnini, M Valenti, S Mukenge, I Matias, A Bianchetti, S Di Palo, G Ferla, V Di Marzo, and T Croci
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P
Gut, July 1, 2006; 55(7): 946 - 953.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Cao, K. M. Harnett, and V. E. Pricolo
NK2 Receptor-Mediated Spontaneous Phasic Contractions in Normal and Ulcerative Colitis Human Sigmoid Colon
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1349 - 1355.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.